172@29@17@140!~!172@29@0@53!~!|news|tags|stempeutics-research.html!~!news|moneycontrol|com!~!|controller|tag.php!~!is_mobile=false
stempeutics research
Jump to
4 Results Found
  • Stempeutics partners with Cipla for its stem cell drug May 18, 2018 02:14 PM IST

    Stempeutics partners with Cipla for its stem cell drug

    "Under this agreement, Cipla will get exclusive marketing rights for five years in India for critical limb ischemia due to atherosclerotic peripheral arterial disease (CLI-PAD) with Stempeutics manufacturing and supplying the product to Cipla," the company said in a statement.

  • Stempeutics gets DCGI nod for stem cell based product May 30, 2016 01:42 PM IST

    Stempeutics gets DCGI nod for stem cell based product

    "The Drugs Controller General (India) has granted limited approval for manufacturing & marketing of stem cell based biological product Stempeucel for the treatment of Buerger's Disease," Cipla, which has investments in Stempeutics, said in a statement.

  • Stempeutics' Stempeucel gets Orphan Drug status in Europe Jun 01, 2015 04:48 PM IST

    Stempeutics' Stempeucel gets Orphan Drug status in Europe

    An orphan designation allows a company to benefit from incentives from the European Union to develop a medicine for a rare disease, such as reduced fees and protection from competition once the medicine is placed on the market.

  • Stem cells industry: The battle within Feb 20, 2013 12:08 PM IST

    Stem cells industry: The battle within

    Fearing that unscrupulous use may hijack this promising field, stakeholders are racing to regulate its applications. Are they swift enough?

Sections